Stevens Capital Management LP Invests $393,000 in Henry Schein, Inc. (NASDAQ:HSIC)

Stevens Capital Management LP purchased a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 5,196 shares of the company’s stock, valued at approximately $393,000.

Other hedge funds also recently bought and sold shares of the company. McGlone Suttner Wealth Management Inc. acquired a new stake in Henry Schein during the fourth quarter worth about $39,000. Baystate Wealth Management LLC grew its position in Henry Schein by 2,500.0% in the third quarter. Baystate Wealth Management LLC now owns 520 shares of the company’s stock worth $39,000 after acquiring an additional 500 shares during the period. Neo Ivy Capital Management purchased a new stake in Henry Schein in the third quarter valued at $46,000. Covestor Ltd grew its holdings in shares of Henry Schein by 22.8% during the 3rd quarter. Covestor Ltd now owns 1,367 shares of the company’s stock worth $102,000 after purchasing an additional 254 shares during the period. Finally, GAMMA Investing LLC acquired a new stake in shares of Henry Schein during the 4th quarter worth about $115,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on HSIC shares. JPMorgan Chase & Co. upped their target price on shares of Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a research report on Wednesday, March 6th. Piper Sandler lifted their price objective on Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a research note on Monday, February 26th. Barrington Research increased their target price on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 28th. Evercore ISI lifted their target price on Henry Schein from $79.00 to $83.00 and gave the company an “in-line” rating in a research report on Wednesday, February 28th. Finally, TheStreet raised shares of Henry Schein from a “c+” rating to a “b-” rating in a research report on Monday, February 26th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $81.09.

Insiders Place Their Bets

In related news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total transaction of $477,620.40. Following the transaction, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the transaction, the chief executive officer now directly owns 73,108 shares in the company, valued at $5,430,462.24. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the sale, the insider now owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Stock Up 0.4 %

Shares of NASDAQ:HSIC traded up $0.31 during trading hours on Friday, reaching $73.13. The stock had a trading volume of 722,374 shares, compared to its average volume of 1,079,516. Henry Schein, Inc. has a 1 year low of $60.01 and a 1 year high of $82.63. The firm’s 50 day moving average is $74.23 and its 200-day moving average is $72.43. The stock has a market capitalization of $9.40 billion, a price-to-earnings ratio of 23.12, a P/E/G ratio of 1.81 and a beta of 0.87. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.00 and a current ratio of 1.67.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, February 27th. The company reported $0.66 EPS for the quarter, missing the consensus estimate of $0.70 by ($0.04). Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The business had revenue of $3.02 billion during the quarter, compared to analysts’ expectations of $3 billion. During the same period last year, the company earned $1.21 EPS. The business’s quarterly revenue was down 10.5% compared to the same quarter last year. Research analysts predict that Henry Schein, Inc. will post 5.07 earnings per share for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.